Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)

Kubota Pharmaceutical Holdings

13/05/2022 07:00

May 13 (Reuters)- 
              Kubota Pharmaceutical Holdings Co., Ltd. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended        Year to  
                  Mar 31, 2022        Mar 31, 2021      Dec 31, 2022  
                     LATEST             YEAR-AGO           COMPANY    
                     RESULTS             RESULT           FORECAST    
  Operating       loss 644 mln        loss 686 mln        loss 2.00   
  Pretax          loss 656 mln        loss 697 mln        loss 2.00   
  Net             loss 656 mln        loss 697 mln        loss 2.00   
  EPS Basic      loss 14.30 yen      loss 15.48 yen    loss 43.61 yen 
  EPS Diluted    loss 14.30 yen      loss 15.48 yen                   
  Ann Div                                  NIL               NIL      
  -Q2 Div                                  NIL               NIL      
  -Q4 Div                                  NIL               NIL      
 
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T